Evidence map›Paper›PMID 39264246›Full record

ReviewClinical cancer research : an official journal of the American Association for Cancer Research2024

Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.

Yoshiko Nakano, Roland P Kuiper, Kim E Nichols, Christopher C Porter, Harry Lesmana, Julia Meade, Christian P Kratz, Lucy A Godley, Luke D Maese, Maria Isabel Achatz and 8 more

Abstract readReview
In one paragraph

Review in Clinical cancer research : an official journal of the American Association for Cancer Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. A novelJournal of pediatric endocrinology & metabolism : JPEM · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yoshiko NakanoDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0001-5394-8194
Roland P KuiperPrincess Máxima Center for Pediatric Oncology and Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0003-4928-3809
Kim E NicholsDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-5581-6555
Christopher C PorterEmory University School of Medicine, Atlanta, Georgia.ORCID 0000-0001-8774-0180
Harry LesmanaDepartment of Pediatric Hematology, Oncology and BMT, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0001-5496-3839
Julia MeadePediatric Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.ORCID 0000-0001-8364-1820
Christian P KratzPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4120-5873
Lucy A GodleyDivision of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois.ORCID 0000-0003-1914-9158
Luke D MaeseHuntsman Cancer Institute, Primary Children's Hospital, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-8739-9100
Maria Isabel AchatzCentro de Oncologia, Hospital Sirio-Libanes, Sao Paulo, Brazil.ORCID 0000-0001-6894-1219
Payal P KhinchaClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.ORCID 0000-0003-2473-7800
Sharon A SavageClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.ORCID 0000-0001-6006-0740
Andrea S DoriaDepartment of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0003-3202-0447
Mary-Louise C GreerDepartment of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0001-6159-5472
Vivian Y ChangPediatric Hematology-Oncology, University of California, Los Angeles, Los Angeles, California.ORCID 0000-0002-4538-1500
Lisa L WangDivision of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-2817-0832
Sharon E PlonDepartment of Pediatrics/Hematology-Oncology, Baylor College of Medicine, Houston, Texas.ORCID 0000-0002-9626-0936
Michael F WalshDivision of Solid Tumor and Clinical Genetics, Department of Medicine and Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-5006-6778

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Genetic Epidemiology of Telomere Maintenance and Cancer EtiologyZ01CP010190 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2006 to 2008
$23k
BMBF ADDRess 01GM2205ADeutsche Kinderkrebsstiftung (German Childhood Cancer Foundation) DKS 2024.03Intramural NIH HHS Z01 CP010190Jeffrey Brock Cancer Genetics Research FellowshipNational Cancer Institute (NCI)NCI NIH HHS L40 CA179863NCI NIH HHS P30 CA008748St. Baldrick's Foundation (SBF)Tokyo Children's Cancer Study Group
6 · The paper itself

Abstract

Genomic instability disorders are characterized by DNA or chromosomal instability, resulting in various clinical manifestations, including developmental anomalies, immunodeficiency, and increased risk of developing cancers beginning in childhood. Many of these genomic instability disorders also present with exquisite sensitivity to anticancer treatments such as ionizing radiation and chemotherapy, which may further increase the risk of second cancers. In July 2023, the American Association for Cancer Research held the second Childhood Cancer Predisposition Workshop, where multidisciplinary international experts discussed, reviewed, and updated recommendations for children with cancer predisposition syndromes. This article discusses childhood cancer risks and surveillance recommendations for the group of genomic instability disorders with predominantly recessive inheritance, including the DNA repair disorders ataxia telangiectasia, Nijmegen breakage syndrome, Fanconi anemia, xeroderma pigmentosum, Bloom syndrome, and Rothmund-Thomson syndrome, as well as the telomere biology disorders and mosaic variegated aneuploidy. Recognition of children with genomic instability disorders is important in order to make the proper diagnosis, enable genetic counseling, and inform cancer screening, cancer risk reduction, and choice of anticancer therapy.

Indexed as

Early Detection of CancerGenomic InstabilityNeoplasmsChildGenetic Predisposition to DiseaseHumansPractice Guidelines as Topic

Identifiers

PMID39264246
PMCPMC11705613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.